Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

COHERUS BIOSCIENCES, INC. REDWOOD CITY 94065

UEI: SLED_4DC19B2297975206

COHERUS BIOSCIENCES, INC. REDWOOD CITY 94065 is a federal contractor, registered under UEI SLED_4DC19B2297975206. It has been awarded $27,626,788 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_4DC19B2297975206

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Coherus Biosciences, Inc. provides pharmaceutical manufacturing and biological product development services. Their technical expertise is centered on the production of pharmaceutical preparations, specifically within the biological products sector. The company supports the Department of Veterans Af...

Coherus Biosciences, Inc. provides pharmaceutical manufacturing and biological product development services. Their technical expertise is centered on the production of pharmaceutical preparations, specifically within the biological products sector. The company supports the Department of Veterans Affairs, delivering specialized pharmaceutical solutions to meet the healthcare needs of veterans. Their industry focus is concentrated under NAICS 325412, specializing in the manufacturing of pharmaceutical preparations. This positions the company as a provider of critical medical countermeasures and therapeutic biologicals. Coherus Biosciences, Inc. is based in Redwood City, California.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Type Over Time
Award Size Distribution
Awards by Place of Performance

Compete with COHERUS BIOSCIENCES, INC. REDWOOD CITY 94065

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for COHERUS BIOSCIENCES, INC. REDWOOD CITY 94065

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 900+ contractors already using CLEATUS

Open opportunities in COHERUS BIOSCIENCES, INC. REDWOOD CITY 94065's top NAICS codes and agencies

NAICS: 325412
New
Federal
Morphine Sulfate Solution
Solicitation # SPE2D2-26-R-0017
Solicitation SPE2D2-26-R-0017 is a request for a national requirements contract for Morphine Sulfate solution, used for managing moderate to severe acute and chronic pain. The contract is managed by DLA Troop Support for the Department of War, Indian Health Service, Bureau of Prisons, and Department of Veterans Affairs. The procurement is restricted to domestic sources providing both Active Pharmaceutical Ingredients and Final Dosage Forms to support the Made in America initiative and national security. The estimated total value of the action is $32,311,688.10, covering a one-year base period and four one-year option periods. The scope includes the provision of Morphine Sulfate solution in various concentrations (2 MG/ML, 4 MG/ML, and 10 MG/ML) across injection syringes and intravenous vials. Award will be based on trade-off source selection procedures, where non-price factors, including basic requirements and past performance, are significantly more important than price. All manufacturing facilities must comply with FDA current Good Manufacturing Practices, and offerors must possess an FDA-approved New Drug Application, abbreviated NDA, or Biologic License approval. Strict packaging and labeling standards are required, including the use of child-proof closures, specific cylindrical bottle dimensions, and GS1-128 or HIBC bar-coding that encodes the National Drug Code. Proposals must be submitted electronically via the Defense Logistics Agency Internet Bid Board System by December 21, 2026. The contractor must be ready to fill orders 45 calendar days after the award, with a total contract duration not exceeding five years.
DLA Troop Support

POSTED

about 12 hours ago

DEADLINE

in about 1 month
View Details